Depreciation in USD of Indaptus Therapeutics, Inc. from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Indaptus Therapeutics, Inc. quarterly/annual Depreciation history and change rate from 2020 to 2024.
  • Indaptus Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $735.000, a 129% increase year-over-year.
  • Indaptus Therapeutics, Inc. annual Depreciation for 2024 was $735.000, a 42.8% decline from 2023.
  • Indaptus Therapeutics, Inc. annual Depreciation for 2023 was $1.28K, a 27.9% decline from 2022.
  • Indaptus Therapeutics, Inc. annual Depreciation for 2022 was $1.78K, a 26.9% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Indaptus Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $735 +$414 +129% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $321 -$213 -39.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $534 +$321 +151% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $213 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

Indaptus Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $735 -$549 -42.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $1.28K -$497 -27.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $1.78K +$378 +26.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $1.4K +$551 +64.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $852 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.